Research Study in Patients with Persistent Macular Edema - Article Water Retention
Clinical Trial: Research Study in Patients with Persistent Macular Edema
This study is no longer recruiting patients.
The purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication to treat macular edema that persists despite current treatment methods. Participants will be evaluated for improvement in vision and side effects.
Macular edema is a condition that affects the back of the eye (retina). It frequently occurs in people who have a history of diabetes, and is also associated with high blood pressure, uveitis, and previous eye surgery. The main symptom of macular edema is decreased vision, generally a blurring of central vision.
There are no direct costs to participants for assessments and treatment as defined in the study protocol. All candidates must be available for required scheduled visits during the trial’s 6-month follow-up period. Although the disease called age-related macular degeneration (AMD) affects the same region of the eye as macular edema, they are not the same condition and AMD is not studied in this research trial.
|Condition||Treatment or Intervention||Phase|
| Drug: DEX PS DDS® ||Phase II |
MedlinePlus related topics: Diabetes; Diabetic Eye Problems; Eye Diseases; Retinal Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Ages Eligible for Study: 12 Years and above, Genders Eligible for Study: Both
Inclusion: Persistent macular edema associated with diabetic retinopathy, uveitis, retinal vein occlusion, or Irvine-Gass syndrome, persisting at least 90 days after laser treatment or medical management by a physician.
Exclusion: Females who are pregnant or lactating, and females of childbearing potential not using adequate birth control for the duration of the study. Any intraocular procedures or laser treatment less than 90 days before enrollment.
Oculex Pharmaceuticals, Sunnyvale, California, United States
Record last reviewed: September 2002
Last Updated: October 13, 2004
Record first received: May 6, 2002
ClinicalTrials.gov Identifier: NCT00035906
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Cache Date: April 9, 2005
- ClinicalTrials.gov: Edema (National Institutes of Health)
- DASH Eating Plan (National Heart, Lung, and Blood Institute) - Links to PDF File